Trial
NCT03767439
Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Columbia University
Collaborators
—
Condition
Basal Cell Nevus Syndrome
Intervention
Vismodegib
Why stopped
Loss of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-18